Navigation Links
KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
Date:3/25/2008

ST. LOUIS, March 25 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVA/KVB), a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technology differentiated branded and generic/non-branded prescription pharmaceutical products, announced the filing of its fiscal 2007 Form 10-K with the Securities and Exchange Commission.

The filing includes restatements of previously reported results for fiscal years 1995 through 2006. In addition, the Company filed a Form 10-QA for the quarter ended June 30, 2006 and Form 10-Q's for the quarters ended September 30, 2006 and December 31, 2006. These filings complete the Company's previously announced restatement of financial results. The financial statements for fiscal 2007 included in the Form 10-K filed with the Securities and Exchange Commission are consistent with the previously reported unaudited financial information which was detailed in a press release dated February 15, 2008.

The Company is currently in the process of completing its Form 10-Q's for the fiscal quarters ended June 30, 2007, September 30, 2007 and December 31, 2007. The filing of the fiscal 2007 10-K brings the Company into compliance with the annual reporting conditions for continued trading on the New York Stock Exchange. However, KV will remain on the NYSE late filer list until its fiscal 2008 quarterly filings are completed.

The Company's filings have been delayed due to the previously reported investigation by a Special Committee of independent members of the Board of Directors into the Company's former stock option grant practices. The investigation concluded that no employee, officer or director of the Company engaged in any intentional wrongdoing or was aware that the Company's policies and procedures for granting and accounting for stock options were materially non-compliant with U.S. Generally Accepted Accounting Principles. The investigation also found no intentio
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
2. MAP Pharmaceuticals Appoints H. Ward Wolff to Board of Directors
3. Sales and Marketing Effectiveness in Pharmaceutical Companies Increases Brand Performance
4. Conatus Pharmaceuticals Appoints Anthony W. Fox, MD, Ph.D., as Chief Medical Officer
5. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
6. Dreier LLP Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated (VRTX)
7. Alseres Pharmaceuticals, Inc. Raises $5 Million
8. Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
9. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
10. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated
11. Sagent Pharmaceuticals Launches Ciprofloxacin Injection, USP, 5% Dextrose Premix Bag
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... 5 There have been significant scientific advances in ... to gain a better understanding of how certain diseases ... provide patients with the best care. Research presented today ... of Hematology explores optimal induction therapies for managing multiple ...
(Date:12/5/2009)... CAPE TOWN, South Africa, December 5 The ... outskirts of Cape Town opened its doors,today (5 ... joined by,Western Cape Premier Helen Zille, 2010 FIFA ... Jordaan, South African Football Association,President Kirsten Nematandani and ...
(Date:12/5/2009)... NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative ... Research presented today at the 51st Annual Meeting ... new treatment options and improved diagnostic methods for ... leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that ...
(Date:12/5/2009)... myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the ... tying the knot, since research has shown that never-married adults ... there something wrong with those who go it alone anyway? ... psychological measures shows that never-married people aged 40 and up ...
(Date:12/5/2009)... new international private medical insurance plan which follows the acclaimed modular ... flexibility to add or remove a wide range of options to ... their benefits to complement those already offered in their country of ... ...
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:AVIVA's Private Health Insurance Products Solutions Go International 2
... March 19 NHS Choices ( http://www.nhs.uk ), ... new Good Food package aimed to,help people achieve ... improved,knowledge of the nutritional content of the food ... the Live Well package,( http://www.nhs.uk/Livewell/loseweight/Pages/Goodfoodhomehome.aspx ) enables,users to ...
... 19 Digirad Corporation,(Nasdaq: DRAD ), ... products,and services to physicians, offices, hospitals and ... has appointed veteran healthcare executive,John W. Sayward ... Mr. Sayward, 56, has more than 30 ...
... the HIV/AIDS epidemic increases food insecurity in African cities ... chances of this happening is the focus of a ... and Southern African expertise will be used in developing ... crucial issue. , Funded by the Canadian International Development ...
... of California,s Quality-in-Sights ... Hospital Incentive Program, THOUSAND ... Cross) today announced the introduction of its,Quality-in-Sights Hospital Incentive Program ... financial incentives with quality,improvements. It uses select indicators that have ...
... to drug-resistant bacteria, CDC study finds , , WEDNESDAY, March ... Staphylococcus aureas bacterium and caught outside of the ... States than previously believed, preliminary research suggests. , "Over ... of a severe CAP [community-acquired pneumonia] caused by ...
... Texas, Struggling Medicaid,Program, AUSTIN, Texas, March 19 ... proposed budget and regulatory,changes that will cut Medicare-financed nursing ... ahead - the 4th highest level of cuts in ... per day - national,and state long term care leaders ...
Other Medicine News:Health News:Digirad Corporation Appoints John W. Sayward to Its Board of Directors 2Health News:Digirad Corporation Appoints John W. Sayward to Its Board of Directors 3Health News:Digirad Corporation Appoints John W. Sayward to Its Board of Directors 4Health News:Food insecurity linked with HIV/AIDS in Africa 2Health News:Blue Cross of California Introduces Pay-for-Performance Hospital Program 2Health News:Community-Based Staph Pneumonia More Common Than Thought 2Health News:New Analysis of Bush FY 2009 Budget: Texas Medicare Cuts 4th Highest in Nation 2Health News:New Analysis of Bush FY 2009 Budget: Texas Medicare Cuts 4th Highest in Nation 3
(Date:12/4/2009)... of imported drugs often stored in tin cans and car ... senior advocacy group RetireSafe urged the Senate to defeat the ... Phillips said, "Senator Dorgan,s importation amendment is poised to open ... breached, and our health to be endangered. We could ...
(Date:12/4/2009)... N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: ... today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed ... Food and Drug Administration seeking approval to market its ... patent owned by Takeda Pharmaceutical Company Limited. Watson,s ...
(Date:12/4/2009)... RARITAN, N.J., Dec. 4 Depression, anxiety disorder, ... disorder and migraine: These are among the comorbidities ... said they had been diagnosed with epilepsy versus ... survey of approximately 173,000 households across the U.S. ...
Breaking Medicine Technology:RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 1Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 2Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 3Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 4Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 5Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting 54852 6COSHAR Foundation Enhances National Childhood Immunization Awareness Campaign 54849 1COSHAR Foundation Enhances National Childhood Immunization Awareness Campaign 54849 2Los Gatos Research Introduces Second Generation Liquid Water Isotope Analyzer 13628 1Los Gatos Research Introduces Second Generation Liquid Water Isotope Analyzer 13628 2
... American Life League,s historic Personhood Conference is ... stem cell research and regenerative medicine.(Logo: ... and CEO of AVM Biotechnology and President ... on over 17 years of experience in ...
... Pfizer Inc. has agreed to provide the ... unique set of electrocardiographic data that will help researchers ... drugs. This is the first time a major ... from one of its drug safety trials, including data ...
Other Medicine Technology:Stem Cell Pioneer to Speak to A.L.L. Personhood Conference 2Pfizer Contributes Critical Data to URMC Drug Safety Initiative 2Pfizer Contributes Critical Data to URMC Drug Safety Initiative 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: